photo
Speaker

Asthika Goonewardene

MANAGING DIRECTOR, EQUITY RESEARCH, BIOTECH, TRUIST SECURITIES
Asthika Goonewardene is a Managing Director at Truist Securities covering biotechnology companies with a focus on cell therapy, immuno-oncology, and antibody technology. Prior to joining the STRH Biotech team in 2019, Mr Goonewardene was a senior analyst with Bloomberg Intelligence, leading coverage of the global biotech sector. Before joining Bloomberg in 2011, Mr Goonewardene worked as a senior management consultant at Datamonitor. He started his career as an analyst at OSI Pharmaceuticals in 2005, and first joined the sell-side in 2007, with the biotech team at Piper Jaffray in London. Mr Goonewardene holds a BS in Biotechnology and an MBA in Technology Management from Rochester Institute of Technology.
Speaking In
11:00 AM - 12:00 PM (EST)
Tuesday, February 16
Frequently altered driver genes in cancer, such as RAS, TP53 and MYC, are attractive targets for…